Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (5)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Laitinen, T.
Right arrow Articles by Peräkylä, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Laitinen, T.
Right arrow Articles by Peräkylä, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Protein Engineering, Vol. 13, No. 4, 247-252, April 2000
© 2000 Oxford University Press

Inversion of the roles of the nucleophile and acid/base catalysts in the covalent binding of epoxyalkyl xyloside inhibitor to the catalytic glutamates of endo-1,4-ß-xylanase (XYNII): a molecular dynamics study

Tuomo Laitinen2, Juha Rouvinen and Mikael Peräkylä1

Department of Chemistry, University of Joensuu, PO Box 111, Joensuu, FIN-80101 and 1 Department of Chemistry, University of Kuopio, PO Box 1627, Kuopio, FIN-70211, Finland

X-Ray crystal structures have revealed that 2,3-epoxypropyl-ß-D-xyloside reacts with endo-1,4-ß-xylanase (XYNII) by forming a covalent bond with Glu86. In contrast, 3,4-epoxybutyl-ß-D-xyloside forms a covalent bond with Glu177. In the normal enzyme reaction Glu86 acts as the catalytic nucleophile and Glu177 as the acid/base catalyst. To rationalize the observed reactivity of the two mechanism-based inhibitors, we carried out eight 300 ps molecular dynamics simulations for different enzyme–inhibitor complexes. Simulations were done for both stereo isomers (R and S) of the inhibitors and for enzyme in which the protonation state of the nucleophile and acid/base catalyst was normal (Glu86 charged, Glu177 neutral) and in which the roles of the catalytic residues were reversed (Glu86 neutral, Glu177 charged). The number of reactive conformations found in each simulation was used to predict the reactivity of epoxy inhibitors. The conformation was considered to be a reactive one when at the same time (i) the proton of the catalytic acid was close (<2.9/3.4/3.9 Å) to the oxirane oxygen of the inhibitor, (ii) the nucleophile was close to the terminal carbon of the oxirane group (<3.4/3.9/4.4 Å) and (iii) the nucleophile approached the terminal carbon from a reactive angle (<30/45/60° from an ideal attack angle). On the basis of the number of reactive conformations, 2,3-epoxypropyl-ß-D-xyloside was predicted to form a covalent bond with Glu86 and 3,4-epoxybutyl-ß-D-xyloside with Glu177, both in agreement with the experiment. Thus, the MD simulations and the X-ray structures indicate that in the covalent binding of 3,4-epoxybutyl-ß-D-xyloside the roles of the catalytic glutamates of XYNII are reversed from that of the normal enzyme reaction.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
GlycobiologyHome page
B. P Rempel and S. G Withers
Covalent inhibitors of glycosidases and their applications in biochemistry and biology
Glycobiology, August 1, 2008; 18(8): 570 - 586.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.